ARCHIVES

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

This article is from The Cancer Letter archive.

Vol. 19 No. 36 | September 17, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

White House Staff Member Reportedly Says Political Screening Being Carried Out On NCAB Nominations

May 28, 1982

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011